Sectors

PEN
Penumbra, Inc.
323.21
2 x 322.97
1 x 323.12
bid
ask
+
0.24
0.07%
11:58 AM
timesize
Ytd 3.96%
1y 17.39%
322.69
day range
324.08
221.26
52 week range
362.41
Open 323.19 Prev Close 322.97 Low 322.69 High 324.08 Mkt Cap 12.71B
Vol 115.20K Avg Vol 568.97K EPS 4.33 P/E 74.62 Forward P/E 51.25
Beta 0.73 Short Ratio 3.51 Inst. Own 96.06% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 07-28 50-d Avg 330.88 200-d Avg 299.38 1yr Est 363.36
Earning
Date For Estimate Reported Surprise surprise %
2026-05-06 2026-03 1.11 0.82 -0.29 -26.13%
2026-02-25 2025-12 1.12 1.18 0.06 5.36%
2025-11-05 2025-09 0.9 0.97 0.07 7.78%
2025-07-29 2025-06 0.81 0.86 0.05 6.17%
2025-04-23 2025-03 0.66 0.83 0.17 25.76%
2025-02-18 2024-12 0.91 0.97 0.06 6.59%
Upgrade / Downgrade
Date Firm Action From To
2026-05-07 Citigroup Upgrade Neutral Neutral
2026-05-07 Evercore ISI Group Upgrade Outperform Outperform
2026-02-26 Evercore ISI Group Upgrade Outperform Outperform
2026-01-20 RBC Capital Downgrade Outperform Sector Perform
2026-01-20 Canaccord Genuity Downgrade Buy Hold
2026-01-16 Jefferies Downgrade Buy Hold
Profile
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Insider Holder
Date Name Relation Quantity Description
2026-02-12 BOSE ARANI Director 259.61K Stock Award(Grant)
2025-09-02 ELSESSER ADAM Chief Executive Officer 760.04K Conversion of Exercise of derivative security
2026-04-01 GREWAL HARPREET SINGH Director 8.72K Sale
2025-02-13 KASSING DON W Director 9.91K Stock Award(Grant)
2026-02-12 LEEDS JANET Director 6.64K Stock Award(Grant)
2026-02-16 NARAYAN SHRUTHI President 30.87K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 FMR, LLC 5.13M 1.66B 13.05%
2026-03-30 Blackrock Inc. 4.33M 1.40B 11.01%
2026-03-30 Vanguard Capital Management LLC 1.69M 546.98M 4.31%
2026-03-30 Vanguard Portfolio Management LLC 1.65M 534.07M 4.21%
2025-12-30 Price (T.Rowe) Associates Inc 1.64M 530.71M 4.18%
2025-12-30 State Street Corporation 1.16M 373.61M 2.94%
Fund Ownership
Report Date Organization Position Value Percentage
2026-03-30 iShares Trust-iShares Core S&P Mid-Cap ETF 1.30M 419.94M 3.31%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.17M 376.82M 2.97%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 844.20K 272.51M 2.15%
2025-12-30 T. Rowe Price Health Sciences Fund, Inc. 536.11K 173.06M 1.36%
2026-02-27 VANGUARD WORLD FUND-Vanguard U.S. Growth Fund 502.94K 162.35M 1.28%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund 476.21K 153.72M 1.21%
Split
Split Date
1 : 10 2014-11-16